Cormorant Asset Management’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
Other funds holding CLYM
Cormorant Asset Management's CLYM Position: Q3 2026 in Review
Cormorant Asset Management held its Climb Bio (CLYM) position steady in Q3 2026 at 2,106,000 shares worth $24.2M. The position accounts for 1.62% of the portfolio, ranked #20.
Cormorant Asset Management first reported a position in CLYM in Q2 2026 and has held it in 2 quarters since. The position peaked at $27.5M in Q2 2026. 128 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.
- Cormorant Asset Management held 2,106,000 shares of Climb Bio worth $24.2M as of Q3 2026.
- Cormorant Asset Management left its Climb Bio share count unchanged in Q3 2026.
- Climb Bio made up 1.62% of Cormorant Asset Management's portfolio in Q3 2026, its #20 holding.
- Cormorant Asset Management first reported a position in Climb Bio in Q2 2026 and has held it in 2 quarters since.
- Cormorant Asset Management's Climb Bio position peaked at $27.5M in Q2 2026.
- 128 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.
Based on Cormorant Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.